433 related articles for article (PubMed ID: 17924555)
1. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
2. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.
Auerbach AD; Greenbaum J; Pujara K; Batish SD; Bitencourt MA; Kokemohr I; Schneider H; Lobitzc S; Pasquini R; Giampietro PF; Hanenberg H; Levran O;
Hum Mutat; 2003 Feb; 21(2):158-68. PubMed ID: 12552564
[TBL] [Abstract][Full Text] [Related]
6. The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability.
Tachibana A; Kato T; Ejima Y; Yamada T; Shimizu T; Yang L; Tsunematsu Y; Sasaki MS
Hum Mutat; 1999; 13(3):237-44. PubMed ID: 10090479
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.
Levran O; Diotti R; Pujara K; Batish SD; Hanenberg H; Auerbach AD
Hum Mutat; 2005 Feb; 25(2):142-9. PubMed ID: 15643609
[TBL] [Abstract][Full Text] [Related]
8. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations of the FANCG gene causing alternative splicing in Japanese Fanconi anemia.
Yamada T; Tachibana A; Shimizu T; Mugishima H; Okubo M; Sasaki MS
J Hum Genet; 2000; 45(3):159-66. PubMed ID: 10807541
[TBL] [Abstract][Full Text] [Related]
10. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.
Chandra S; Levran O; Jurickova I; Maas C; Kapur R; Schindler D; Henry R; Milton K; Batish SD; Cancelas JA; Hanenberg H; Auerbach AD; Williams DA
Mol Ther; 2005 Nov; 12(5):976-84. PubMed ID: 16084127
[TBL] [Abstract][Full Text] [Related]
11. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of Fanconi anaemia--an old problem, a new insight.
Ahmad SI; Hanaoka F; Kirk SH
Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
[TBL] [Abstract][Full Text] [Related]
13. The Fanconi anaemia group G gene FANCG is identical with XRCC9.
de Winter JP; Waisfisz Q; Rooimans MA; van Berkel CG; Bosnoyan-Collins L; Alon N; Carreau M; Bender O; Demuth I; Schindler D; Pronk JC; Arwert F; Hoehn H; Digweed M; Buchwald M; Joenje H
Nat Genet; 1998 Nov; 20(3):281-3. PubMed ID: 9806548
[TBL] [Abstract][Full Text] [Related]
14. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
16. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
Taniguchi T; D'Andrea AD
Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
Kachnic LA; Li L; Fournier L; Willers H
Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
[TBL] [Abstract][Full Text] [Related]
18. X-linked inheritance of Fanconi anemia complementation group B.
Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H
Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827
[TBL] [Abstract][Full Text] [Related]
19. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
20. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
